SS
VRTX icon

Sunbelt Securities’s Vertex Pharmaceuticals VRTX Stock Holding History

Sunbelt Securities’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$456K Sell
1,022
-4
-0.4% -$1.86K 0.03% 429
2025
Q4 		$465K Sell
1,026
-12
-1% -$5.17K 0.03% 422
2025
Q3 		$407K Buy
1,038
+3
+0.3% +$1.25K 0.03% 438
2025
Q2 		$417K Hold
1,035
– – 0.04% 393
2025
Q1 		$502K Hold
1,035
– – 0.04% 324
2024
Q4 		$413K Sell
1,035
-646
-38% -$299K 0.04% 397
2024
Q3 		$782K Sell
1,681
-65
-4% -$31.2K 0.08% 245
2024
Q2 		$818K Sell
1,746
-3
-0.2% -$1.3K 0.08% 225
2024
Q1 		$731K Buy
1,749
+561
+47% +$237K 0.08% 227
2023
Q4 		$483K Sell
1,188
-10
-0.8% -$3.69K 0.06% 317
2023
Q3 		$417K Buy
1,198
+653
+120% +$228K 0.06% 327
2023
Q2 		$192K Buy
545
+50
+10% +$16.8K 0.03% 469
2023
Q1 		$155K Buy
+495
New +$148K 0.02% 480

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Sunbelt Securities's VRTX Position: Q1 2026 in Review

Sunbelt Securities reduced its Vertex Pharmaceuticals (VRTX) stake by 0.39% in Q1 2026, selling an estimated $1.86K and leaving 1,022 shares worth $456K. The position accounts for 0.03% of the portfolio, ranked #429.

Sunbelt Securities first reported a position in VRTX in Q1 2023 and has held it in 13 quarters since. The position peaked at $818K in Q2 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Sunbelt Securities held 1,022 shares of Vertex Pharmaceuticals worth $456K as of Q1 2026.
  • Sunbelt Securities sold 4 Vertex Pharmaceuticals shares in Q1 2026, an estimated $1.86K.
  • Vertex Pharmaceuticals made up 0.03% of Sunbelt Securities's portfolio in Q1 2026, its #429 holding.
  • Sunbelt Securities first reported a position in Vertex Pharmaceuticals in Q1 2023 and has held it in 13 quarters since.
  • Sunbelt Securities's Vertex Pharmaceuticals position peaked at $818K in Q2 2024.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.